| Migraine |
1 |
1 |
| Pain |
0 |
0.8 |
| Headache |
0 |
1 |
| Pain Management |
0 |
0.55 |
| Nerve |
0 |
0.42 |
| Otolaryngology |
0 |
0.39 |
| Cluster Headaches |
0 |
0.29 |
| Frontal Region |
0 |
0.13 |
| Adolescent Medicine |
0 |
0.1 |
| Aura |
0 |
0.1 |
| Brain |
0 |
0.1 |
| Medication Overuse Headache (MOH) |
0 |
0.1 |
| Orbit |
0 |
0.1 |
| Monoclonal Antibody |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Biologic Therapy |
0 |
0.04 |
| Depression |
0 |
0.04 |
| Adverse Effects |
0 |
0.03 |
| Burns |
0 |
0.03 |
| Cervical Region |
0 |
0.03 |
| Emesis |
0 |
0.03 |
| Food and Drug Administration (FDA) |
0 |
0.03 |
| Insurance |
0 |
0.03 |
| Menstrual Migraine |
0 |
0.03 |
| Mouth |
0 |
0.03 |
| Nausea |
0 |
0.03 |
| Nose |
0 |
0.03 |
| Occiput |
0 |
0.03 |
| Paresthesia |
0 |
0.03 |
| Primary Care |
0 |
0.03 |
| PubMed |
0 |
0.03 |
| Pupil |
0 |
0.03 |
| Suicide |
0 |
0.03 |
| Tryptamine |
0 |
0.03 |
| Constipation |
0 |
0.02 |
| Patient Safety |
0 |
0.02 |
| Revenue and Practice Management |
0 |
0.02 |
| Wound Management |
0 |
0.02 |